Back

Evolocumab for Early Reduction of LDL-Cholesterol Levels in Patients with Acute Coronary Syndromes

31 August 2019 (09:17 - 09:35)
Organised by:
Congress Presentation Part of: Late Breaking Science in Acute Coronary Syndromes 1 Lipid-Lowering Agents ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Konstantinos Koskinas

Bern University Hospital, Inselspital, Bern (Switzerland)

3 More presentations in this session

Presentation thumbnail
A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes: The Australian GRACE Risk score Intervention Study
Professor D. Brieger (Concord, AU)
Slides Video
Presentation thumbnail
COMBinAtion Therapy with remote ischemic conditioning and exenatide in Myocardial Infarction. Primary results of The COMBAT-MI trial
Doctor I. Otaegui Irurueta (Barcelona, ES)
Slides Video
Presentation thumbnail
Randomised comparison of clopidogrel versus ticagrelor or prasugrel in patients of 70 years or older with non-ST-elevation acute coronary syndrome - POPular AGE
Miss M. Gimbel (Nieuwegein, NL)
Slides Video

Access the full session

Session thumbnail
Late Breaking Science in Acute Coronary Syndromes 1

The Event

Event poster

ESC Congress 2019

31 August 2019 09:17 CET
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Congress Presentation
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
thumbnail
Webinar
New trial evidence in the field of lipid management

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources